Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
An index fund comprises a tracking index, a diversified portfolio, and governance controls designed to mirror the index’s performance.
16,264 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Insider moves can spark questions about a regional bank's future. This guide explains what a director selling shares ...
Viomi (VIOT) 2025 earnings are shaping up as a pivotal moment for this IoT home player. This guide breaks down what t...
Micron Technology stunned investors with a massive quarterly upside. This article breaks down why micron technology's...
The Pitt's latest season dives into a hospital cyberattack, a scenario many experts say echoes real-world risk in hea...
Nvidia dominates AI GPUs, but Broadcom could offer a different path into AI growth. This article lays out three concr...
Quantum computing stocks ionq, Rigetti, and D-Wave have captured investor imaginations with big promises and big vola...
Elon Musk is stirring the pot once again with Terafab, the newest idea from elon that aims to redefine manufacturing ...
President Trump issues an emergency payroll directive for TSA workers as the DHS shutdown drags on, hoping to relieve...
Colombia unveils a bold plan to turn the Caribbean coast into a bitcoin mining hub powered by renewable energy, tying...
Is Occidental Petroleum a solid buy, a risky hold, or a limited-scope sell? This guide breaks down the business, the ...
OpenPayd’s Chief Commercial Officer explains how a unified financial infrastructure and growing stablecoins are accel...